Logo image
Chlamydia
Book chapter   Peer reviewed

Chlamydia

L M Hafner and Peter Timms
Sexually Transmitted Diseases: Vaccines, Prevention and Control, 2nd Edition, pp.369-410
Elsevier Inc., 2nd Edition
2013
url
https://doi.org/10.1016/B978-0-12-391059-2.00015-2View
Published Version

Abstract

Microbiology Chlamydia trachomatis vaccine development
Chlamydial infections of humans can cause blindness and infertility as a result of diseases such as keratoconjunctivitis (trachoma), urethritis and cervicitis. However, in greater than half of all chlamydial diseases in males and females there are no signs or symptoms of infection. Chlamydia trachomatis is the causative bacterial organism responsible for the global estimate of 40.6 million people currently suffering with active trachoma and for the five million new cases of sexually transmitted infections each year in the United States of America. Even though antibiotics are available to treat Chlamydia, the incidence of each of these primarily asymptomatic infections continues to increase. In this Chapter we review the current knowledge of C.trachomatis including clinicial diseases and sequelae, the chlamydial developmental cycle in vivo, immunobiology and immune responses to infections, chlamydial genomics and vaccine development.

Details

Metrics

2 File views/ downloads
630 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Web Of Science research areas
Infectious Diseases

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image